Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi India Ltd Board/Management Information 2021

Nov 24, 2021

59270_rns_2021-11-24_94821842-47ce-4892-932a-16150ba99684.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [89 x 71] intentionally omitted <==

24[th] November 2021

The Secretary, The Secretary, Bombay Stock Exchange Limited, The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] Floor, Dalal Street, Plot No. C/1, G Block, Mumbai 400 001 Bandra-Kurla Complex, Bandra East, Mumbai 400 050

Resignation of Non-Executive Director

Dear Sirs,

As required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has received a letter today, from Mr. Cyril Grandchamp-Desraux stating that he would like to resign as the Non-Executive Director of the Company due to personal reasons with immediate effect from 24[th] November 2021. (date of receipt of letter).

The Company places on record its appreciation for the contribution made by Mr. Cyril Grandchamp-Desraux during his tenure as Non-Executive Director of the Company.

Please take the above information on record.

Thanking you,

Yours sincerely, SANOFI INDIA LIMITED

==> picture [106 x 49] intentionally omitted <==

RADHIKA SHAH COMPANY SECRETARY & COMPLIANCE OFFICER

==> picture [468 x 13] intentionally omitted <==